Radiopharm Theranostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	34.52	29.12	18.58	11.7	26.98	0.03
Cash & Short-Term Investments	34.52	29.12	18.58	11.7	26.98	0.03
Cash Growth	-5.27%	56.75%	58.77%	-56.64%	99486.97%	-
Accounts Receivable	11.36	-	-	0.1	0.06	-
Other Receivables	-	10.4	0.99	4.36	0	0.01
Receivables	11.36	10.4	0.99	4.47	0.06	0.01
Other Current Assets	0.17	0.34	3.29	0.13	0.23	-
Total Current Assets	46.04	39.85	22.85	16.3	27.26	0.03
Property, Plant & Equipment	0.05	0.05	0.06	0.07	0	-
Other Intangible Assets	45.08	46.57	49.09	58.54	56.08	-
Other Long-Term Assets	-	-	0.04	0.04	0.04	-
Total Assets	91.17	86.48	72.04	74.95	83.38	0.03
Accounts Payable	10.72	6.35	6.43	2.96	1.19	0.06
Accrued Expenses	0.58	3.2	2.57	2.11	1.02	0.03
Short-Term Debt	-	-	-	-	-	0.06
Current Unearned Revenue	1.02	1.72	-	-	-	-
Other Current Liabilities	2.99	3.66	8.57	8.16	5.66	-
Total Current Liabilities	15.3	14.93	17.58	13.23	7.88	0.16
Other Long-Term Liabilities	25.94	28.68	27.11	16.14	12.54	-
Total Liabilities	41.23	43.61	44.68	29.37	20.42	0.16
Common Stock	209.94	176.56	100.68	97.23	86.76	0
Retained Earnings	-172.37	-145.73	-111.34	-65.35	-30.91	-0.49
Comprehensive Income & Other	14.22	13.97	38.78	12.51	7.11	0.36
Total Common Equity	51.78	44.79	28.12	44.38	62.96	-0.12
Minority Interest	-1.84	-1.92	-0.77	1.19	-	-
Shareholders' Equity	49.94	42.87	27.35	45.58	62.96	-0.12
Total Liabilities & Equity	91.17	86.48	72.04	74.95	83.38	0.03
Total Debt	-	-	-	-	-	0.06
Net Cash (Debt)	34.52	29.12	18.58	11.7	26.98	-0.03
Net Cash Growth	-5.27%	56.75%	58.77%	-56.64%	-	-
Net Cash Per Share	0.01	0.01	0.05	0.04	0.15	-
Filing Date Shares Outstanding	2,568	2,365	2,173	339.31	255.43	100
Total Common Shares Outstanding	2,568	2,365	460.37	339.31	255.43	100
Working Capital	30.75	24.92	5.27	3.07	19.39	-0.12
Book Value Per Share	0.02	0.02	0.06	0.13	0.25	-0.00
Tangible Book Value	6.7	-1.78	-20.96	-14.16	6.89	-0.12
Tangible Book Value Per Share	0.00	-0.00	-0.05	-0.04	0.03	-0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q